- Home
- HESM vs FOLD Comparison
HESM vs FOLD Comparison
Compare HESM & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HESM | FOLD |
|---|---|---|
| Founded | 2014 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 4.5B |
| IPO Year | 2019 | 2006 |
Fundamental Metrics
Financial Performance| Metric | HESM | FOLD |
|---|---|---|
| Price | $38.26 | $14.49 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 9 |
| Target Price | ★ $41.00 | $27.25 |
| AVG Volume (30 Days) | 1.5M | ★ 2.5M |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | ★ 8.08% | N/A |
| EPS Growth | N/A | ★ 50.00 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,621,300,000.00 | N/A |
| Revenue This Year | $1.59 | $20.50 |
| Revenue Next Year | $3.10 | $18.59 |
| P/E Ratio | $13.07 | ★ N/A |
| Revenue Growth | ★ 8.41 | N/A |
| 52 Week Low | $31.63 | $5.66 |
| 52 Week High | $44.14 | $14.50 |
Technical Indicators
Market Signals| Indicator | HESM | FOLD |
|---|---|---|
| Relative Strength Index (RSI) | 51.01 | 74.18 |
| Support Level | $36.85 | $14.21 |
| Resistance Level | $40.36 | N/A |
| Average True Range (ATR) | 0.80 | 0.02 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 54.03 | 100.00 |
Price Performance
Historical ComparisonAbout HESM Hess Midstream LP Share
Hess Midstream LP owns, operates, develops, and acquires a diverse set of midstream assets and provides fee-based services to Hess and third-party customers. It conducts its business through three operating segments: gathering, processing and storage, and terminaling and exporting. The company derives the maximum revenue from the gathering segment. Its gathering segment consists of the following assets namely Natural Gas Gathering and Compression; Crude Oil Gathering and Produced Water Gathering and Disposal.
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused to develop and deliver transformative medicines for people living with rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.